GlassScriptPhysician profile
Katie Ellen Wall
NPI 1649584384
$7,639.74
in general payments reported to CMS, 2019-2025
38 companies · $2,003 in 2025
The $2,003 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $366 · 2022: $988 · 2023: $1,734 · 2024: $2,549 · 2025: $2,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,910 · Honoraria: $750 · Travel and Lodging: $436 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,909.80 |
| Honoraria | $750.00 |
| Travel and Lodging | $436.01 |
| Education | $189.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $1,109.70 | 2022-2025 | Jelmyto |
| Telix Pharmaceuticals | $900.21 | 2024 | Illuccix |
| Janssen Biotech, INC. | $638.00 | 2024-2025 | Erleada, Carvykti, Rybrevant |
| Astellas Pharma US INC | $467.36 | 2021-2024 | Xtandi, Veozah, Myrbetriq |
| Coloplast Corp | $417.07 | 2023-2025 | Speedicath |
| Pfizer INC. | $416.59 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $337.79 | 2023-2025 | Gemtesa, Orgovyx |
| Merck Sharp & Dohme LLC | $326.54 | 2022-2024 | Keytruda, Lynparza |
| Ferring Pharmaceuticals INC. | $245.81 | 2024-2025 | Adstiladrin |
| Axonics, INC. | $245.80 | 2022-2023 | Axonics, Bulkamid |
| Medtronic, INC. | $221.46 | 2022-2023 | Interstim |
| Abbvie INC. | $214.22 | 2021-2025 | |
| Dendreon Pharmaceuticals LLC | $206.30 | 2023-2025 | Provenge |
| Progenics Pharmaceuticals, INC. | $200.74 | 2024-2025 | |
| Endo USA, INC. | $194.17 | 2024-2025 | Xiaflex, Aveed |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $179.31 | 2024-2025 | Xt Cdx, Tempus Pixel |
| Teleflex LLC | $168.91 | 2021-2025 | Urolift, Barrigel |
| Blue Earth Diagnostics | $132.36 | 2024-2025 | Posluma |
| 180 Medical, INC. | $125.39 | 2022-2023 | Gentlecath |
| Calyxo, INC. | $89.77 | 2024 | Cvac Aspiration System |
| Urovant Sciences INC | $88.47 | 2022 | |
| Dentsply Ih Ab | $85.09 | 2024 | Lofric |
| Endo Pharmaceuticals INC. | $79.83 | 2021-2024 | Aveed, Xiaflex |
| Boston Scientific Corporation | $76.03 | 2021-2025 | Rezum Generator |
| Myovant Sciences INC. | $70.26 | 2021 | |
| Myriad Genetic Laboratories, INC. | $62.98 | 2021-2024 | Prolaris |
| Genzyme Corporation | $47.65 | 2022 | |
| Laborie Medical Technologies Corp. | $38.43 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Tolmar Pharmaceuticals, INC. | $33.42 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $29.36 | 2024 | Balversa, Erleada, Akeega |
| Novartis Pharmaceuticals Corporation | $28.98 | 2025 | |
| Convatec INC. | $28.89 | 2021 | |
| Tolmar, INC. | $28.37 | 2023 | |
| Hollister Incorporated | $25.29 | 2021 | |
| Immunitybio, INC. | $22.41 | 2024 | |
| Ambu INC. | $21.53 | 2024 | |
| Rochester Medical Corporation | $17.74 | 2021 | |
| Abc Home Medical Supply, INC. | $17.51 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Wall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.